AstraZeneca Pharma India Discloses Pending Litigation to NSE
AstraZeneca Pharma India has submitted regulatory intimation to the National Stock Exchange regarding pending litigation and disputes affecting the company.
Read articleAI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.
1 articles published
Results for “ASTRAZEN” · in NSE filings — Clear filters
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.